Clinical Trials Directory

Trials / Completed

CompletedNCT03872674

A Trial Comparing High-flow Nasal Oxygen With Standard Management for Conscious Sedation During Endoscopic Retrograde Cholangiopancreatography in Prone Position

A Randomized Controlled Trial Comparing High-flow Nasal Oxygen With Standard Management for Conscious Sedation During Endoscopic Retrograde Cholangiopancreatography in Prone Position

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

Traditional conscious sedation for endoscopic retrograde cholangiopancreatography in prone position places patients at risk of desaturation, and high-flow nasal oxygen may reduce the risk. The aim of this study is to evaluate the role of high-flow nasal oxygen during endoscopic retrograde cholangiopancreatography. The investigators will compare the lowest SpO2 of standard nasal oxygen cannula group and that of high-flow humidified oxygen-delivery system group during the procedure.

Conditions

Interventions

TypeNameDescription
BIOLOGICALhigh-flow humidified oxygen-delivery system (OptiFlow THRIVE)stand oxygenation arm will receive oxygen at 5 L/min via nasal cannula, while Optiflow THRIVE arm will receive oxygen at 50 L/min via Optiflow THRIVE during the procedure.

Timeline

Start date
2019-04-01
Primary completion
2019-04-18
Completion
2019-04-18
First posted
2019-03-13
Last updated
2019-05-09

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03872674. Inclusion in this directory is not an endorsement.